In this course, learners will receive an overview of the application of the fundamentals of immunology in patients with rheumatoid arthritis.
Christopher Palma, MD, ScM
University of Rochester Medical Center
The target audience for the forum includes registered nurses (RNs), nurse practitioners (NPs), physician assistants (PAs), and other healthcare professionals who are engaged in clinical practice, education, research, and advocacy for the care of adult and pediatric patients with rheumatic diseases.
In this issue of Rheumatology Nurse Practice, we review the latest PsA treatment guidelines and offer insight into how these recommendations can be translated into clinical practice. We also discuss data regarding the efficacy and safety of various classes of DMARDs, including conventional synthetic, biologic, and targeted small-molecule agents, and examine how providers can optimize their patients’ chances of treatment success with these options.
- Identify the current trends of practices impacting age appropriate care and treatment of the rheumatology patient.
- Incorporate into practice the current state of the science and research in several common and rare rheumatic diseases.
- Interpret exam findings and employ best practices for patients with rheumatic diseases.
- Identify the risk factors in evaluating patient responses to disease severity and treatments
The Rheumatology Nurses Society is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (Provider No. P0500).
Participants will receive 0.75 hours of continuing nursing contact hours by completing the education, completing an online evaluation, and receiving a post-test score of 70%.
According to the disclosure policy of the Rheumatology Nurses Society, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence.
Planners, reviewers, and faculty have disclosed no conflicts of interest related to the content of this education.
Method of Participation:
There are no fees to participate in the activity. Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CNE contact hours for your participation, please complete the post-test (achieving a passing grade of 70% or greater), and program evaluation. Your certificate can be printed immediately.
Horizon Therapeutics USA, Inc., Janssen, and Pfizer
© 2021. This CNE-certified activity is held as copyrighted © by Rheumatology Nurses Society. Through this notice, the Rheumatology Nurses Society grants permission of its use foreducational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).
Date of Expiration: November 12, 2021